PETER FLEMING: Open Payments
NPI 1801553656 · ONEIDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 28 payments from 11 companies in 2025. Trend: 2023 $503 · 2024 $478 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $284 |
| GENZYME CORPORATION | 3 | $241 |
| Regeneron Healthcare Solutions, Inc. | 5 | $217 |
| AERIN MEDICAL INC. | 1 | $150 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $37 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Smith+Nephew, Inc. | 1 | $21 |
| Optinose US, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
Products named: DUPIXENT, NUCALA, VIVAER STYLUS, Xhance, NEFFY, TULA, INSPIRE, PROPEL.
Industry payments across NY — which companies pay providers there.
